Crossmark

Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model

Crossref DOI link: https://doi.org/10.1038/srep46468

Published Online: 2017-04-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Ghobashy, Medhat A.

ElMeshad, Aliaa N.

Abdelsalam, Rania M.

Nooh, Mohammed M.

Al-Shorbagy, Muhammad

Laible, Götz
License Information

Text and Data Mining valid from 2017-04-20

Version of Record valid from 2017-04-20
More Information

Article History

Received: 4 October 2016

Accepted: 15 March 2017

First Online: 20 April 2017

Competing interests

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below